Label genetically modified salmon

Salmon hold sacred status in the Pacific Northwest, literally for the people of the region’s Indian nations. But the rest of us, specifically those who fish for salmon and those who serve them at family meals, also regard the fish as part of our heritage.

So it’s not hard to understand the skepticism and outright opposition to salmon that has been genetically modified. The moniker some have given it, “Frankenfish,” gives a good idea of its lack of acceptance.

Earlier this month, the U.S. Food and Drug Administration approved the sale of genetically engineered salmon, the first time an animal, rather than a plant, has been approved as safe for human consumption.

A Massachusetts-based company, AquaBounty has developed an Atlantic salmon that, through the introduction of genes from an eel-like fish and growth hormone from a chinook salmon, grows large enough for sale in a year and a half rather than the typical three years.

The FDA, the Washington Post reported, said its decision was “based on sound science and a comprehensive review” that the genetically engineered salmon was as a safe as Atlantic salmon to eat and was not discernibly different in terms of its nutritional value.

But at the same time the FDA said it would not require the salmon to carry a label that identified it as being genetically modified, claiming that it can’t require additional labeling unless there’s a substantial nutritional difference between the genetically modified product and its nonmodified counterpart.

That decision to approve AquaBounty’s salmon without a labeling requirement met appropriate criticism, including from U.S. Sen. Maria Cantwell, D-Washington and Rep. Don Young, R-Alaska.

“Wild seafood from Washington and Alaska are more sustainable than frankenfish, and our consumers have a right to know where their fish come from,” Sen. Cantwell said.

The House had an opportunity earlier this summer to reject legislation that could now pre-empt any mandatory state or local labeling requirements for GMO foods, in favor of a voluntary state-administered system. The bill passed the House, with Washington state’s delegation voting on a party line; Republicans for, Democrats, including Reps. Rick Larsen and Suzan DelBene, against. Alaska’s Young, despite his long opposition to GMO salmon, voted for the less-stringent voluntary system.

New legislation that would allow the FDA to require GMO labeling would give consumers the ability to make their own choice in the matter. Meanwhile, some retail outlets are making that choice. Costco, Whole Foods, Kroger (Fred Meyer) and others are refusing to sell the GMO salmon when it comes on the market.

The genetic alteration of our food has a history almost as old as agriculture itself as farmers and ranchers have bred and crossbred plants and animals for desirable traits, such as increased yields and better flavor. The difference now, reports a Q&A from National Geographic, is that science allows that crossbreeding to cross species, resulting in salmon with eel-fish genes that grow more quickly or lettuce that gets its vitamin C from of an introduced rat gene.

This is a relatively new science that holds promise but also potential harm to health and the environment.

AquaBounty is being required to raise its salmon in landlocked tanks to prevent any possible interbreeding with wild salmon. Aqua-Bounty has taken the further precaution of raising only sterile females.

The science of genetic engineering should be allowed to progress, as should the careful and considered review of its products. Labeling those products after they are approved has to be a part of the process.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Thursday, May 16

A sketchy look at the news of the day.… Continue reading

Attorney General Bob Ferguson speaks to a reporter as his 2024 gubernatorial campaign launch event gets underway in Seattle, on Saturday, Sept. 9, 2023. ( Jerry Cornfield/Washington State Standard)
Editorial: Recruiting two Bob Fergusons isn’t election integrity

A GOP activist paid the filing fee for two gubernatorial candidates who share the attorney general’s name.

Foster parent abstract concept vector illustration. Foster care, father in adoption, happy interracial family, having fun, together at home, childless couple, adopted child abstract metaphor.
Editorial: State must return foster youths’ federal benefits

States, including Washington, have used those benefits, rather than hold them until adulthood.

Comment; Congress is broken, but term limits won’t fix it

Looking at term limits in state legislatures, such reforms have resulted in several drawbacks.

Michelle Goldberg: Cohen a cautionary tale for Republicans

Donald Trump’s former fixer now regrets the loyalty he paid to his boss. Are others paying attention?

Bret Stephens: The worst enemy of a ‘free Palestine’ is Hamas

Unless Hamas is defeated, a Palestinian state led by it would defy the values of campus protesters.

Paul Krugman: Biden’s tariffs meant to hold off next ‘China shock’

China’s goal to flood U.S. market with green-energy products would harm U.S. climate efforts.

Making adjustments to keep Social Security solvent represents only one of the issues confronting Congress. It could also correct outdated aspects of a program that serves nearly 90 percent of Americans over 65. (Stephen Savage/The New York Times) -- NO SALES; FOR EDITORIAL USE ONLY WITH NYT STORY SLUGGED SCI SOCIAL SECURITY BY PAULA SPAN FOR NOV. 26, 2018. ALL OTHER USE PROHIBITED.
Editorial: Social Security’s good news? Bad news delayed a bit

Congress has a little additional time to make sure Social Security is solvent. It shouldn’t waste it.

Senate Majority Leader Chuck Schumer (D-N.Y.) speaks to reporters during a press conference about the Cannabis Administration and Opportunity Act, on Capitol Hill in Washington, on Wednesday, May 1, 2024. Senate Democrats reintroduced broad legislation on Wednesday to legalize cannabis on the federal level, a major shift in policy that has wide public support, but which is unlikely to be enacted this year ahead of November’s elections and in a divided government. (Valerie Plesch/The New York Times)
Editorial: Federal moves on cannabis encouraging, if incomplete

The Biden administration and the Senate offer sensible proposals to better address marijuana use.

toon
Editorial cartoons for Wednesday, May 15

A sketchy look at the news of the day.… Continue reading

Comment: Turning 65? Here’s what to know about Medicare

You have options, but you’ll need to ask yourself some questions before picking a plan that fits your needs.

James Bouie: Presidents judged on handling crisis; except Trump

Many give Trump a pass over his leadership during the covid pandemic. Do we risk another crisis?

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.